Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
1.800
+0.040 (2.27%)
At close: Nov 7, 2025, 4:00 PM EST
1.830
+0.030 (1.67%)
After-hours: Nov 7, 2025, 7:07 PM EST
Mereo BioPharma Group Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$7.40
Upside
+311.11%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $7 → $8 | Buy | Maintains | $7 → $8 | +344.44% | Aug 25, 2025 |
| Needham | Needham | Strong Buy Maintains $7 → $5 | Strong Buy | Maintains | $7 → $5 | +177.78% | Jul 10, 2025 |
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +288.89% | May 13, 2025 |
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +288.89% | Apr 9, 2025 |
| JP Morgan | JP Morgan | Buy Initiates $7 | Buy | Initiates | $7 | +288.89% | Mar 27, 2025 |
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +288.89% | Mar 26, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +288.89% | Mar 18, 2025 |
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +288.89% | Jan 13, 2025 |
| LifeSci Capital | LifeSci Capital | Buy Initiates $10 | Buy | Initiates | $10 | +455.56% | Dec 24, 2024 |
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +288.89% | Dec 17, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +288.89% | Dec 6, 2024 |
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +288.89% | Nov 12, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +288.89% | Oct 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +288.89% | Sep 16, 2024 |
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +288.89% | Aug 13, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $7 | Buy | Reiterates | $7 | +288.89% | Jul 22, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.